These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4108789)

  • 61. [Serological studies on the incidence of complement-fixing antibodies against cytomegalovirus in Westberlin].
    Henneberg G; Antoniadis G
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):416-27. PubMed ID: 4318515
    [No Abstract]   [Full Text] [Related]  

  • 62. [Study of that portion of the population of Leningrad that is immune to cytomegalovirus].
    Shavrina LV; Asher DL; Il'enko VI; Smorodintsev AA
    Vopr Virusol; 1973; 18(2):156-9. PubMed ID: 4350236
    [No Abstract]   [Full Text] [Related]  

  • 63. Partial characterization of a soluble antigen preparation from cells infected with human cytomegalovirus: properties of antisera prepared to the antigen.
    Waner JL
    J Immunol; 1975 May; 114(5):1454-7. PubMed ID: 164507
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Production of immune sera to respiratory syncytial virus].
    Ponomareva TI; Dreĭzin RS
    Vopr Virusol; 1968; 13(1):109-13. PubMed ID: 4971966
    [No Abstract]   [Full Text] [Related]  

  • 65. [Placental transmission of cytomegalovirus CF-antibodies].
    Antoniadis G; Jordanski H
    Zentralbl Bakteriol Orig; 1971; 216(4):428-34. PubMed ID: 4326009
    [No Abstract]   [Full Text] [Related]  

  • 66. Serologic responses to herpes simplex virus in rabbits: complement-requiring neutralizing, conventional neutralizing, and passive hemagglutinating antibodies.
    Lerner AM; Shippey MJ; Crane LR
    J Infect Dis; 1974 Jun; 129(6):623-36. PubMed ID: 4365944
    [No Abstract]   [Full Text] [Related]  

  • 67. PREPARATION AND STANDARDIZATION OF COXSACKIEVIRUS REFERENCE ANTISERA. I. FOR TWENTY-FOUR GROUP A VIRUSES.
    KAMITSUKA PS; LOU TY; FABIYI A; WENNER HA
    Am J Epidemiol; 1965 May; 81():283-306. PubMed ID: 14294414
    [No Abstract]   [Full Text] [Related]  

  • 68. [The duration of Cytomegalovirus complement fixation antibodies in patients with CMV hepatitis].
    Kaynar V; Durusu Z
    Mikrobiyol Bul; 1981 Jan; 15(1):31-4. PubMed ID: 6300616
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS.
    PLUMMER G; BENYESH-MELNICK M
    Proc Soc Exp Biol Med; 1964 Oct; 117():145-50. PubMed ID: 14219928
    [No Abstract]   [Full Text] [Related]  

  • 70. Blastogenic response of human lymphocytes to human cytomegalovirus.
    Waner JL; Budnick JE
    Clin Exp Immunol; 1977 Oct; 30(1):44-9. PubMed ID: 203423
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A vesicular stomatitis virus (cytomegalovirus) pseudotype and its use in neutralization tests.
    Vonka V; Závadová H; Poláková D
    Intervirology; 1979; 12(1):32-8. PubMed ID: 227814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigations on the antigenic heterogeneity of human fibrinogen and plasminogen.
    Bauer K
    Klin Wochenschr; 1970 Apr; 48(7):443-5. PubMed ID: 4107055
    [No Abstract]   [Full Text] [Related]  

  • 73. Neutralization kinetic studies with genital cytomegalovirus isolates, an antigenically variable group.
    Weller TH; Waner JL; Hopkins DR; Allred EN
    IARC Sci Publ (1971); 1978; (24 Pt 1):177-84. PubMed ID: 87363
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibodies against adeno-, cytomegalo and rubella viruses in Australia-antigen-negative sera from patients with infectious hepatitis.
    Alwen J; Emmerson AM
    J Hyg (Lond); 1974 Jun; 72(3):433-9. PubMed ID: 4367226
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neutralization of residual infectivity of Venezuelan equine encephalomyelitis virus by anti-gamma globulin.
    Hahon N
    J Gen Virol; 1970 Mar; 6(3):361-72. PubMed ID: 4984703
    [No Abstract]   [Full Text] [Related]  

  • 76. Antibodies to feline oncornavirus group-specific antigens in feline sera.
    Yohn DS; Olsen RG
    Bibl Haematol; 1973; 39():744-54. PubMed ID: 4130403
    [No Abstract]   [Full Text] [Related]  

  • 77. RUBELLA COMPLEMENT FIXATION TEST.
    SEVER JL; HUEBNER RJ; CASTELLANO GA; SARMA PS; FABIYI A; SCHIFF GM; CUSUMANO CL
    Science; 1965 Apr; 148(3668):385-7. PubMed ID: 14261535
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of purified cytomegalovirus as antigen in the complememt fixation test.
    Andersen HK; Haahr S; Sarov I
    Scand J Infect Dis; 1977; 9(2):159-60. PubMed ID: 197593
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.
    The TH; Klein G; Langenhuysen MM
    Clin Exp Immunol; 1974 Jan; 16(1):1-7,9-12. PubMed ID: 4143184
    [No Abstract]   [Full Text] [Related]  

  • 80. Assessment of human cytomegalovirus antibody detection techniques.
    Horodniceanu F; Michelson S
    Arch Virol; 1980; 64(4):287-301. PubMed ID: 6249241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.